Pentobarbital sodium is a short-acting barbiturate that depresses the central nervous system by enhancing the inhibitory action of GABA. It has been used as a sedative-hypnotic, anticonvulsant, and anesthetic, with current use largely limited to veterinary medicine. Due to its narrow therapeutic index, it carries significant risks including respiratory depression, dependence, and potential for misuse, and is therefore strictly regulated. It is grouped under the following drug class(es): Barbiturates, Controlled drug substances, Hypnotics and Sedatives. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Napental, Vetbutal, Auropan and Embutal. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 23676152.
Pentobarbital sodium
| CAS No | 57-33-0 |
|---|---|
| Molecular Formula | C11H17N2NaO3 |
| Molecular Weight | 248.25 g/mol |
| Synonyms | sodium;5-ethyl-4,6-dioxo-5-pentan-2-yl-1H-pyrimidin-2-olate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pentobarbital sodium is a short-acting barbiturate that depresses the central nervous system by enhancing the inhibitory action of GABA. It has been used as a sedative-hypnotic, anticonvulsant, and anesthetic, with current use largely limited to veterinary medicine.
The listed CAS number is 57-33-0.
The listed molecular formula is C11H17N2NaO3.
The listed molecular weight is 248.25 g/mol.
sodium;5-ethyl-4,6-dioxo-5-pentan-2-yl-1H-pyrimidin-2-olate.
The source lists Napental, Vetbutal, Auropan and Embutal.